$SYRS Syros Pharmaceuticals, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Syros Pharmaceuticals, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Syros Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Syros Pharmaceuticals, Inc. for free.

CIK Number: 0001556263
IRS Number: 453772460
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: SYRS
Company Address: 35 CAMBRIDGE PARK DRIVE CAMBRIDGE 02140
Phone number: 617-744-1340
Former name: LS22, Inc., date of change: 2012-08-15

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.

Market Capitalization: $249.93M
Prev close: $10.92
Average Daily Volume: 22,044
Days Low: $10.53
Year Low: $8.16
Year High: $21.50

Syros Pharmaceuticals, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Ferra Joseph J JrChief Financial Officer00Feb 19 20213 months ago
Olson Eric RChief Scientific Officer3,62839,618shares bought: 34,378 / shares sold: -36,131 SELLMar 17 20212 months ago
Roth DavidChief Medical Officer00Feb 19 20213 months ago
Simonian Nancy APresident & CEO544,4505,945,394shares bought: 311,973 / shares sold: 0 STRONG BUYFeb 19 20213 months ago
Springhorn Jeremy P.Chief Business Officer15,000163,800shares bought: 15,000 / shares sold: 0 BUYFeb 19 20213 months ago
Young Richard ADirector321,7113,513,084shares bought: 0 / shares sold: -99,598 STRONG SELLFeb 18 20213 months ago

View all Syros Pharmaceuticals, Inc. insiders.

Syros Pharmaceuticals, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 17 2021SYRSSyros Pharmaceutic ...Olson Eric RChief Scientific Of ...Option ExerciseM1.013,6283,66490,697
Mar 17 2021SYRSSyros Pharmaceutic ...Olson Eric RChief Scientific Of ...SellS9.473,62834,37203.6 K to 0 (-100.00 %)
Mar 17 2021SYRSSyros Pharmaceutic ...Olson Eric RChief Scientific Of ...BuyM1.013,6283,6643,6280 to 3.6 K
Feb 19 2021SYRSSyros Pharmaceutic ...Springhorn Jeremy P.Chief Business Offi ...Option ExerciseA11.4194,0001,072,54094,000
Feb 19 2021SYRSSyros Pharmaceutic ...Olson Eric RChief Scientific Of ...Option ExerciseA11.4194,0001,072,54094,000
Feb 19 2021SYRSSyros Pharmaceutic ...Roth DavidChief Medical Offic ...Option ExerciseA11.41119,0001,357,790119,000
Feb 19 2021SYRSSyros Pharmaceutic ...Ferra Joseph J JrChief Financial Off ...Option ExerciseA11.41119,0001,357,790119,000
Feb 19 2021SYRSSyros Pharmaceutic ...Simonian Nancy APresident & CEOOption ExerciseA11.41304,0003,468,640304,000
Feb 18 2021SYRSSyros Pharmaceutic ...Young Richard ADirectorSellS12.053,75045,188321,711325.5 K to 321.7 K (-1.15 %)
Feb 10 2021SYRSSyros Pharmaceutic ...Young Richard ADirectorSellS13.043,75048,900325,461329.2 K to 325.5 K (-1.14 %)
Dec 21 2020SYRSSyros Pharmaceutic ...Simonian Nancy APresident & CEOOption ExerciseM10.094,98850,329280,012
Dec 21 2020SYRSSyros Pharmaceutic ...Simonian Nancy APresident & CEOOption ExerciseM8.5114,168120,57079,165
Dec 21 2020SYRSSyros Pharmaceutic ...Simonian Nancy APresident & CEOOption ExerciseM3.0410,76132,71321,524
Dec 21 2020SYRSSyros Pharmaceutic ...Simonian Nancy APresident & CEOBuyM10.094,98850,329563,606558.6 K to 563.6 K (+0.89 %)
Dec 21 2020SYRSSyros Pharmaceutic ...Simonian Nancy APresident & CEOBuyM8.5114,168120,570558,618544.5 K to 558.6 K (+2.60 %)

View all Syros Pharmaceuticals, Inc. insider transactions.